Discover

STAA
STAAR Surgical Company
22.18
2 x 16.92
1 x 29.05
bid
ask
+
0.07
0.34%
10:25 AM
timesize
Ytd-3.92%
1y-18.91%
21.78
day range
22.17
15.59
52 week range
35.87
Open22.07Prev Close22.11Low21.78High22.17Mkt Cap1.11B
Vol79.42KAvg Vol834.38KEPS0.08P/E276.56Forward P/E21.60
Beta1.26Short Ratio4.02Inst. Own111.61%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1150-d Avg25.68200-d Avg24.121yr Est27.90
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-042026-100.2N/AN/AN/A
2026-08-122026-070.220.16-0.06-27.73%
2026-05-132026-040.050.380.33600.85%
2026-03-032026-010.18-0.2-0.38-211.11%
2025-11-052025-090.180.460.28155.56%
2025-08-062025-06-0.56-0.340.2239.38%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-17StifelUpgradeHoldHold
2026-08-13UBSUpgradeSellSell
2026-08-13WedbushUpgradeOutperformOutperform
2026-08-04WedbushUpgradeOutperformOutperform
2026-07-28UBSUpgradeSell
2026-07-22WedbushUpgradeOutperformOutperform
Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Insider Holder
DateNameRelationQuantityDescription
2026-08-13ANDREWS DEBORAH JChief Financial Officer38.91KConversion of Exercise of derivative security
2026-03-12BROADWOOD PARTNERS, L.P.Beneficial Owner of more than 10% of a Class of Security0.00Purchase
2026-06-17BUTCHER ARTHUR CDirector9.55KConversion of Exercise of derivative security
2025-03-04FARRELL STEPHEN CChief Executive Officer35.16KConversion of Exercise of derivative security
2026-08-13FOUST WARRENChief Executive Officer95.82KConversion of Exercise of derivative security
2026-06-17JIANG WEIDirector77.13KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Broadwood Capital, Inc.16.12M356.50M32.16%
2026-06-29Blackrock Inc.6.73M148.83M13.42%
2026-06-29Madison Avenue Partners, LP4.18M92.33M8.33%
2026-06-29Yunqi Capital Ltd3.26M72.02M6.50%
2026-06-29Point72 Asset Management, L.P.2.44M53.89M4.86%
2026-06-29Goldman Sachs Group Inc2.15M47.55M4.29%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-07-30iShares Trust-iShares Core S&P Small-Cap ETF3.03M67.04M6.05%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.10M24.23M2.19%
2026-06-29iShares Trust-iShares Russell 2000 ETF883.58K19.54M1.76%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund799.83K17.68M1.60%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund556.76K12.31M1.11%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund454.67K10.05M0.91%
Split
SplitDate
1 : 21992-05-18